213 related articles for article (PubMed ID: 18625101)
1. Intrathecal analgesia for refractory cancer pain.
Newsome S; Frawley BK; Argoff CE
Curr Pain Headache Rep; 2008 Aug; 12(4):249-56. PubMed ID: 18625101
[TBL] [Abstract][Full Text] [Related]
2. Spinal analgesia for severe cancer pain: A retrospective analysis of 60 patients.
Kiehelä L; Hamunen K; Heiskanen T
Scand J Pain; 2017 Jul; 16():140-145. PubMed ID: 28850391
[TBL] [Abstract][Full Text] [Related]
3. Intrathecal betamethasone for cancer pain in the lower half of the body: a study of its analgesic efficacy and safety.
Taguchi H; Oishi K; Sakamoto S; Shingu K
Br J Anaesth; 2007 Mar; 98(3):385-9. PubMed ID: 17227818
[TBL] [Abstract][Full Text] [Related]
4. Epidural and intrathecal analgesia for cancer pain.
Kedlaya D; Reynolds L; Waldman S
Best Pract Res Clin Anaesthesiol; 2002 Dec; 16(4):651-65. PubMed ID: 12516896
[TBL] [Abstract][Full Text] [Related]
5. Neuraxial infusion in patients with chronic intractable cancer and noncancer pain.
Osenbach RK; Harvey S
Curr Pain Headache Rep; 2001 Jun; 5(3):241-9. PubMed ID: 11309212
[TBL] [Abstract][Full Text] [Related]
6. Sustained-release oral morphine versus transdermal fentanyl and oral methadone in cancer pain management.
Mercadante S; Porzio G; Ferrera P; Fulfaro F; Aielli F; Verna L; Villari P; Ficorella C; Gebbia V; Riina S; Casuccio A; Mangione S
Eur J Pain; 2008 Nov; 12(8):1040-6. PubMed ID: 18353696
[TBL] [Abstract][Full Text] [Related]
7. A retrospective comparison of intrathecal morphine and epidural hydromorphone for analgesia following posterior spinal fusion in adolescents with idiopathic scoliosis.
Hong RA; Gibbons KM; Li GY; Holman A; Voepel-Lewis T
Paediatr Anaesth; 2017 Jan; 27(1):91-97. PubMed ID: 27878902
[TBL] [Abstract][Full Text] [Related]
8. Intrathecal drug delivery for the management of cancer pain: a multidisciplinary consensus of best clinical practices.
Stearns L; Boortz-Marx R; Du Pen S; Friehs G; Gordon M; Halyard M; Herbst L; Kiser J
J Support Oncol; 2005; 3(6):399-408. PubMed ID: 16350425
[TBL] [Abstract][Full Text] [Related]
9. Intrathecal catheter-syringe adaptor for short-term intrathecal analgesia with an externalized pump: a case report.
Wilkes D; Cook M; Solanki D
Pain Physician; 2010; 13(2):151-6. PubMed ID: 20309381
[TBL] [Abstract][Full Text] [Related]
10. Prospective Observational Study of Patient-Controlled Intrathecal Analgesia: Impact on Cancer-Associated Symptoms, Breakthrough Pain Control, and Patient Satisfaction.
Brogan SE; Winter NB; Okifuji A
Reg Anesth Pain Med; 2015; 40(4):369-75. PubMed ID: 25923819
[TBL] [Abstract][Full Text] [Related]
11. Validated chromatographic method for the simultaneous determination of eight drugs (morphine, ropivacaine, bupivacaine, baclofen, clonidine, sufentanil, fentanyl and ziconotide) for intrathecal analgesia.
Sorrieul J; Robert J; Gibory V; Collet M; Boutet M; Kieffer H; Folliard C; Dupoiron D; Devys C
Ann Pharm Fr; 2018 May; 76(3):201-209. PubMed ID: 29478715
[TBL] [Abstract][Full Text] [Related]
12. Neuraxial pain relief for intractable cancer pain.
Sloan PA
Curr Pain Headache Rep; 2007 Aug; 11(4):283-9. PubMed ID: 17686392
[TBL] [Abstract][Full Text] [Related]
13. Ketamine combined with morphine for the management of cancer pain in a patient with meperidine tolerance and addiction.
Akin Takmaz S; Inan N; Günal S; Kaymak C; Sakalli M; Dikmen B
Agri; 2005 Jul; 17(3):44-7. PubMed ID: 16158342
[TBL] [Abstract][Full Text] [Related]
14. [Chronic intrathecal drug administration for the control of intractable pain].
Taira T
Brain Nerve; 2008 May; 60(5):509-17. PubMed ID: 18516973
[TBL] [Abstract][Full Text] [Related]
15. Controversies in intrathecal drug delivery for cancer pain.
Brogan SE; Sindt JE; Odell DW; Gulati A; Dupoiron D
Reg Anesth Pain Med; 2023 Jun; 48(6):319-325. PubMed ID: 35977779
[TBL] [Abstract][Full Text] [Related]
16. Plasma concentrations of meperidine and normeperidine following continuous intrathecal meperidine in patients with neuropathic cancer pain.
Vranken JH; van der Vegt MH; van Kan HJ; Kruis MR
Acta Anaesthesiol Scand; 2005 May; 49(5):665-70. PubMed ID: 15836681
[TBL] [Abstract][Full Text] [Related]
17. Spinal analgesia in terminal care: risk versus benefit.
Devulder J; Ghys L; Dhondt W; Rolly G
J Pain Symptom Manage; 1994 Feb; 9(2):75-81. PubMed ID: 8021538
[TBL] [Abstract][Full Text] [Related]
18. Two decades of improved pain control.
Penn RD
J Support Oncol; 2005; 3(6):411-2. PubMed ID: 16350426
[No Abstract] [Full Text] [Related]
19. Use of Microfluidics to Fabricate Bioerodable Lipid Hybrid Nanoparticles Containing Hydromorphone or Ketamine for the Relief of Intractable Pain.
Zhu M; Whittaker AK; Jiang X; Tang R; Li X; Xu W; Fu C; Smith MT; Han FY
Pharm Res; 2020 Oct; 37(10):211. PubMed ID: 33009588
[TBL] [Abstract][Full Text] [Related]
20. Continuous intrathecal hydromorphone and clonidine for intractable cancer pain.
Coombs DW; Saunders RL; Fratkin JD; Jensen LE; Murphy CA
J Neurosurg; 1986 Jun; 64(6):890-4. PubMed ID: 2422332
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
